HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME

被引：5
|
作者：
TOMPKINS, RG
机构：
来源：
CRITICAL CARE MEDICINE | 1994年 / 22卷 / 01期
关键词：
INTERLEUKIN-1; SEPSIS; CYTOKINES; PATIENT OUTCOME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
D O I：
10.1097/00003246-199401000-00002
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] INITIAL EVALUATION OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME - A RANDOMIZED, OPEN-LABEL, PLACEBO-CONTROLLED MULTICENTER TRIAL
    FISHER, CJ
    SLOTMAN, GJ
    OPAL, SM
    PRIBBLE, JP
    BONE, RC
    EMMANUEL, G
    NG, D
    BLOEDOW, DC
    CATALANO, MA
    FRIEDMAN, B
    MURE, A
    SHAPIRO, E
    CRITICAL CARE MEDICINE, 1994, 22 (01) : 12 - 21
  • [2] Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
    Meyer, Nuala J.
    Reilly, John P.
    Anderson, Brian J.
    Palakshappa, Jessica A.
    Jones, Tiffanie K.
    Dunn, Thomas G.
    Shashaty, Michael G. S.
    Feng, Rui
    Christie, Jason D.
    Opal, Steven M.
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 21 - 28
  • [3] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261
  • [4] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [5] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    Journal of Clinical Immunology, 1997, 17 : 253 - 261
  • [6] Interleukin-10 and interleukin-1 receptor antagonist distinguish between patients with sepsis and the systemic inflammatory response syndrome (SIRS)
    Potjo, Moliehi
    Theron, Annette J.
    Cockeran, Riana
    Sipholi, Ndisha N.
    Steel, Helen C.
    Bale, Tsohadi V.
    Meyer, Pieter W. A.
    Anderson, Ronald
    Tintinger, Gregory R.
    CYTOKINE, 2019, 120 : 227 - 233
  • [7] Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils
    Langereis, J. D.
    Oudijk, E-J. D.
    Schweizer, R. C.
    Lammers, J-W. J.
    Koenderman, L.
    Ulfman, L. H.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 406 - 415
  • [8] INTERLEUKIN-1 RECEPTOR ANTAGONIST
    LACHAUX, A
    PEDIATRIE, 1991, 46 (10): : 657 - 661
  • [9] Human interleukin-1β and interleukin-1 receptor antagonist secretion and velocity of tooth movement
    Iwasaki, LR
    Haack, JE
    Nickel, JC
    Reinhardt, RA
    Petro, TM
    ARCHIVES OF ORAL BIOLOGY, 2001, 46 (02) : 185 - 189
  • [10] Expression of interleukin-1 receptor antagonist in human cornea
    Heur, Martin
    Chaurasia, Shyam S.
    Wilson, Steven E.
    EXPERIMENTAL EYE RESEARCH, 2009, 88 (05) : 992 - 994
12345